High-throughput approaches such as chromatin immunoprecipitation sequencing (ChIP-seq) have demonstrated that NOTCH1 and NOTCH2 exhibit distinct chromatin binding profiles in pancreatic cancer cell lines (e.g., BXPC3), suggesting functional divergence and target gene specificity. The gene discussed is NOTCH2; the disease is pancreatic neoplasm.